Efficacy of Nanotechnology in Treatment of Alzheimer's Disease
Efficacy of Nanotechnology in Treatment of Alzheimer's Disease

Author: Aziza Shalby

Publisher: LAP Lambert Academic Publishing

Published: 2014-03

Total Pages: 64

ISBN-13: 9783659430008

DOWNLOAD EBOOK

Targeting of the central nervous system (CNS) in order to treat disorders is actually challenging due to the necessity to cross the blood brain barrier (BBB). This review aims to show how nanomedicine can propose new approach for the treatment of CNS diseases focusing on Alzheimer's disease (AD). AD is a neurodegenerative disorder prevalent in the senile population. It is characterized by severe neuronal loss and proliferation of plaques composed of -amyloid peptide (A ) and Tau protein deposites. The absence of an effective therapeutic approach nowadays could be, in part, due to the bad knowledge of AD physiopathology and the lack of early diagnosis. Many drawbacks such as poor bioavailability or limited BBB arising of tested molecules in the current or new therapeutic strategies explain their failure but can be resolved by the use of nanotechnology. Thus, enhanced drug delivery in AD is needed to induce neuroprotection and therapeutic success. For this purpose, nanodrug delivery could be one of the available options that require active consideration for novel therapeutic strategies to treat AD cases.

Nanomedicine-Based Approaches for the Treatment of Dementia
Nanomedicine-Based Approaches for the Treatment of Dementia

Author: Umesh Gupta

Publisher: Academic Press

Published: 2022-10-11

Total Pages: 320

ISBN-13: 0323859062

DOWNLOAD EBOOK

Nanomedicine-Based Approaches for the Treatment of Dementia explores a wide range of promising approaches for the diagnosis and treatment of dementia. The book begins with introductory sections on dementia and brain ailments that are followed by further chapters that discuss detailed information about challenges of drug delivery across the blood-brain barrier as well as the current status. This book helps readers design and develop novel drug delivery systems and devices for the treatment of dementia that take advantage of recent advances in nanomedical technologies. Numerous drug delivery systems have been developed recently for dementia. Unfortunately, most of them are ineffective since dementia is not a single disease. It is an umbrella term for several neurodegenerative conditions which alter brain functions. Due to this, there is an urgent need for innovative technologies/nano drug delivery systems to improve the targeting and delivery of therapeutic as well as diagnostic agents specifically for treating dementia. - Explores promising approaches for the diagnosis and treatment of dementia - Discusses advances in cutting-edge nanomedical technologies - Focuses on the design, synthesis and application of nanocarriers in drug delivery

Application For Nanotechnology For the Treatment of Brain Diseases and Disorders
Application For Nanotechnology For the Treatment of Brain Diseases and Disorders

Author: Bingyang Shi

Publisher: Frontiers Media SA

Published: 2024-07-15

Total Pages: 84

ISBN-13: 2832551858

DOWNLOAD EBOOK

Brain diseases and disorders, such as dementia and glioblastoma, are among the deadliest diseases in humans, and put an overwhelming burden on healthcare systems. Despite recent progress in elucidating the causes of brain diseases, a limited amount of effective therapeutics have been developed. One major obstacle is the efficient delivery of therapeutic agents across the Blood-Brain Barrier (BBB) into the affected region of the brain. Utilizing nanoparticles as a drug delivery system provides a simple and effective approach, with improved efficacy and bioavailability. In the last two decades, numerous advances have been made in this field, which will bring nanomedicine closer to the clinic and bring new therapeutic options for the treatment of brain diseases which have proved challenging to treat. Such advancements include improvements in the novel design of nanoparticles with tissue compatibility, versatile loading capacity, BBB penetration ability and greater target specificity.

Nanomedical Drug Delivery for Neurodegenerative Diseases
Nanomedical Drug Delivery for Neurodegenerative Diseases

Author: Awesh K. Yadav

Publisher: Academic Press

Published: 2022-03-10

Total Pages: 284

ISBN-13: 0323898017

DOWNLOAD EBOOK

Nanomedical Drug Delivery for Neurodegenerative Diseases opens the door for promising approaches and advances in the diagnosis and treatment of various neurodegenerative diseases. The contents of the book comprise all the aspects related to the design, synthesis, and application of different nanodrug delivery systems in the treatment of neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and motor neuron diseases. This book explores how nanoparticulate drug carriers can improve therapeutic efficacy by selecting a suitable design strategy. Nanomedical Drug Delivery for Neurodegenerative Diseases is a valuable resource for graduates, clinical researchers, and other scientists working to minimize the challenges to deliver the drugs and genes in a more efficient and targeted manner for the treatment of neurodegenerative diseases. - Includes design, synthesis and applications of drug delivery systems - Explores the role of nanotechnology in the diagnosis and treatment of neurodegenerative disorders - Reviews applications for the management of Parkinson's disease, Alzheimer's disease, Huntington's disease, and motor neuron diseases - Discusses extracellular vesicles and mitochondria-targeted bioactive delivery systems - Details how nanocarrier-based delivery is useful to improve efficacy and cure

Progress in Nanomedicine in Neurologic Diseases
Progress in Nanomedicine in Neurologic Diseases

Author: Hari Shanker Sharma

Publisher: Springer Nature

Published: 2023-08-23

Total Pages: 426

ISBN-13: 303132997X

DOWNLOAD EBOOK

This book covers the use of nanomedicine in the delivery of neuroprotective agents, including pharmacological drugs, stem cells, neurotrophic factors, monoclonal antibodies and enzymes to induce greater beneficial effects in neurologic diseases. Thus, the main purpose of the book is to explore the delivery of drugs either alone or in combination with stem cells to enhance neuroprotection in neurological diseases. Brain pathology associated with acute trauma such as head injury and brain blast injury can also be managed using novel treatment strategies. In addition, emphasis is made that standard patterns of brain pathology may be complicated with multiple comorbidity factors where one agent alone is not sufficient to induce brain protection. Enzymes and antibodies may help in combination and enhance the efficacy when administered through nanotechnology. Progress in Nanomedicine in Neurologic Diseases will encourage further research in the field of neuroprotection, brain injury, neurodegenerative diseases, neuropharmacology, neuropathology, and neurology. Students and researchers along with policy makers, teachers and health care professionals may also benefit from the findings of the book for enhanced patients care.

Drug and Gene Delivery to the Central Nervous System for Neuroprotection
Drug and Gene Delivery to the Central Nervous System for Neuroprotection

Author: Hari S. Sharma

Publisher: Springer

Published: 2017-06-05

Total Pages: 237

ISBN-13: 3319576968

DOWNLOAD EBOOK

This book summarizes the latest research on drug and gene delivery to the central nervous system (CNS). The chapters address safety concerns regarding the nanotechnology that is needed to develop nanomedicine for clinical practice. Particular focus is given to new technologies that have emerged in recent years to deliver therapeutic materials, such as genes, drugs, and other agents using nanotechnologies of diverse origin. This is an ideal book for students, teachers, researchers, and clinicians interested in a deeper understanding of nanotechnological advances in therapeutic medicine. This book also: Broadens readers’ understanding of viral vector gene delivery to the brain for treating neurogenetic diseases as well as targeted gene delivery into the brain using microbubble-facilitated focused ultrasound Covers in detail the latest developments in delivering therapeutic materials, such as siRNA delivery to the brain for treating neurological diseases, neuroprotective effects of gelatin nanoparticles in stroke, and nanowired drug delivery for brain diseases, heat stroke, and CNS injury Enriches understanding of new technologies for delivering therapeutic materials treating Alzheimer’s Disease, including targeted nanodrug delivery through the blood-brain barrier and the superior neuroprotective effects of nanowired drug delivery in Alzheimer’s Disease

Alzheimer's Disease Theranostics
Alzheimer's Disease Theranostics

Author: Magisetty Obulesu

Publisher: Academic Press

Published: 2019-02-15

Total Pages: 200

ISBN-13: 9780128164129

DOWNLOAD EBOOK

Alzheimer's Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer's patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of existing maneuvers and suggests perspectives to aid in future developments. Despite the difficulty of drug delivery to the brain, there are some nanoparticulate platforms demonstrating promise in treating neurodegenerative disorders such as Alzheimer's disease. Manifold theranostic maneuvers include antioxidants, natural bioactive compounds, gene therapy, and nanotechnological approaches, all of which are discussed in this important work. Examines various theranostic applications for the diagnosis and treatment of Alzheimer's disease Features a comprehensive overview of nanoparticle therapeutics in the area and use of antioxidants Assesses the common challenges and lessons learned from blood-brain barrier challenges, viral vector approaches and mitochondria-targeted therapeutics

Nanobiotechnology in Neurodegenerative Diseases
Nanobiotechnology in Neurodegenerative Diseases

Author: Mahendra Rai

Publisher: Springer Nature

Published: 2019-12-02

Total Pages: 403

ISBN-13: 3030309304

DOWNLOAD EBOOK

This book focuses on neurodegenerative diseases which have become a major threat to human health. Neurodegenerative diseases are age related disorders and have become increasingly prevalent in the elderly population in recent years. Hence, there is an urgent need to study and develop new strategies and alternative methods for the treatment of neurodegenerative diseases. This book showcases the promises that nanobiotechnology brings in research, diagnosis, and treatment of neurodegenerative diseases. It is very beneficial for varied group of readers including nanotechnologists, biotechnologists, pharmacists, medical professionals, bioengineers, biochemists and researchers working in this field. Nanobiotechnology in Neurodegenerative Diseases include various chapters including neurodegeneration and neurodegenerative diseases, nanotechnology for the rescue of neurodegenerative diseases, promising potential of nanomaterials for diagnosis and therapy of neurodegenerative diseases, nanotechnology mediated nose-to-brain drug delivery, and formulation and characterization of intranasal nanoparticles of antiretroviral drugs.

Reviews on New Drug Targets in Age-Related Disorders
Reviews on New Drug Targets in Age-Related Disorders

Author: Paul C. Guest

Publisher: Springer Nature

Published: 2021-03-16

Total Pages: 274

ISBN-13: 3030550354

DOWNLOAD EBOOK

Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in ‘omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry. This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from ‘omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America, Uruguay and Vietnam, this is a timely follow up to Guest’s previous book Reviews on New Drug Targets in Age-Related Disorders.

Early Diagnosis of Alzheimer’s Disease
Early Diagnosis of Alzheimer’s Disease

Author: Leonard F. M. Scinto

Publisher: Springer Science & Business Media

Published: 2000-02-09

Total Pages: 366

ISBN-13: 1592590055

DOWNLOAD EBOOK

Drs. Leonard Scinto and Kirk Daffner provide a comprehensive survey of new diagnostic approaches to Alzheimer's disease. The authoritative contributors critically survey the most promising current research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by sensitive neuropsychological tests, various genetic markers, and biological assays. Early Diagnosis of Alzheimer's Disease illuminates the complex issues surrounding the search for early markers of this increasingly widespread disease. It will establish a new standard reference guide for all those working with Alzheimer's patients.